FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration...
Map Reveals States Where RSV Cases Are Surging - Newsweek
Dec 31, 2024 · In the week ending December 21, the following three states had the highest percentage of positive RSV tests – Louisiana (25 percent), Massachusetts (24 percent) and Texas (23 percent), according...
Is a virus going around? Details on the flu, COVID, norovirus, RSV
Jan 1, 2025 · Respiratory syncytial virus (RSV) causes infections of the breathing passages and lungs. It's so common that most children have been infected with the virus by age 2, according to the Mayo Clinic .
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
A new vaccine is here to protect you and your loved ones from RSV …
Jan 2, 2025 · December and January are peak months for respiratory syncytial virus (RSV) infections. NIH MedlinePlus Magazine has a handy overview of RSV, how it spreads, and how to protect yourself and others from getting sick. Learn what immunizations are available, including vaccines for older adults and antibodies for infants. Don’t let the winter blues get you down—avoid RSV and stay healthy this ...
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults …
Oct 22, 2024 · First and only respiratory syncytial virus (RSV) vaccine indicated for adults younger than 50; Approval based on data from pivotal Phase 3 trial in adults at increased risk of lower respiratory tract disease caused by RSV
Respiratory Syncytial Virus (RSV) | RSV | CDC - Centers for …
Describes the basics of respiratory syncytial virus (RSV) Information on vaccines to protect adults ages 60 and older against RSV. Information about RSV immunization to protect your baby from severe RSV illness. Clinical information about RSV, including clinical considerations for people at increased risk of se...
Real-world study: RSV vaccine 78% to 80% effective against
2 days ago · The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory virus season against infection, emergency department/urgent care (ED/UC) visits, and hospitalization was 78%, 79%, and 80%, respectively. The findings, published this week in The ...
Progress at last against RSV - Nature Medicine
Sep 14, 2023 · A surge in respiratory syncytial virus (RSV) infections and RSV-related hospitalizations in the 2023 Southern Hemisphere winter, similar to that seen in 2022 in northern climes, has...
‘A good day’: FDA approves world’s first RSV vaccine - Nature
May 3, 2023 · The US Food and Drug Administration (FDA) has approved GSK’s vaccine against respiratory syncytial virus (RSV) for use in people aged 60 years and older. This is the first RSV vaccine to gain...